# Suja Life, Inc.: financial statements, quarterly

SUJA · Nasdaq · CIK 1934114 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 27

Pages: [Overview](/companies/suja.md) · [Financials](/companies/suja/financials.md) · [Filings](/companies/suja/filings.md) · [Insiders](/companies/suja/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/suja/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-29) |
| --- | --- | ---: | ---: |
| Revenue | $m | [75.2](/filings/0001628280-26-052702.md) | [83.9](/filings/0001628280-26-052702.md) |
| Cost of revenue | $m | [39.5](/filings/0001628280-26-052702.md) | [44.7](/filings/0001628280-26-052702.md) |
| Gross profit | $m | [35.6](/filings/0001628280-26-052702.md) | [39.2](/filings/0001628280-26-052702.md) |
| Operating income | $m | [1.9](/filings/0001628280-26-052702.md) | [(20.5)](/filings/0001628280-26-052702.md) |
| Interest expense | $m | [7.5](/filings/0001628280-26-052702.md) | [5.4](/filings/0001628280-26-052702.md) |
| Income tax | $m | [0.1](/filings/0001628280-26-052702.md) | [(0.5)](/filings/0001628280-26-052702.md) |
| Net income | $m | [(5.7)](/filings/0001628280-26-052702.md) | [(3.3)](/filings/0001628280-26-052702.md) |
| Diluted EPS | $ per share | not reported | [(0.14)](/filings/0001628280-26-052702.md) |
| Basic EPS | $ per share | not reported | [(0.14)](/filings/0001628280-26-052702.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-12-29) | period not labelled (2026-03-30) | Q2 FY2026 (2026-06-29) |
| --- | --- | ---: | ---: | ---: |
| Cash and equivalents | $m | [31.0](/filings/0001628280-26-052702.md) | not reported | [20.6](/filings/0001628280-26-052702.md) |
| Current assets | $m | [71.2](/filings/0001628280-26-052702.md) | not reported | [63.4](/filings/0001628280-26-052702.md) |
| Total assets | $m | [428](/filings/0001628280-26-052702.md) | [0.0](/filings/0001628280-26-041958.md) | [419](/filings/0001628280-26-052702.md) |
| Current liabilities | $m | [58.9](/filings/0001628280-26-052702.md) | not reported | [41.4](/filings/0001628280-26-052702.md) |
| Total liabilities | $m | [396](/filings/0001628280-26-052702.md) | [0.0](/filings/0001628280-26-041958.md) | [230](/filings/0001628280-26-052702.md) |
| Long-term debt | $m | [301](/filings/0001628280-26-052702.md) | not reported | [163](/filings/0001628280-26-052702.md) |
| Current portion of debt | $m | [2.7](/filings/0001628280-26-052702.md) | not reported | [0.0](/filings/0001628280-26-052702.md) |
| Shareholders' equity | $m | [32.6](/filings/0001628280-26-052702.md) | not reported | [189](/filings/0001628280-26-052702.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Shares

| Line item | Unit | Q2 FY2026 (2026-06-29) |
| --- | --- | ---: |
| Diluted shares (weighted) | thousands of shares | [23.8](/filings/0001628280-26-052702.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.